Literature DB >> 12695037

Immune responses against excreted/secreted antigens of Toxoplasma gondii tachyzoites in the murine model.

Ahmad Daryani1, Ahmad Zavaran Hosseini, Abdolhossein Dalimi.   

Abstract

In the present study, excretory secretory antigens (ESA) of Toxoplasma gondii were evaluated in immunization of 8-10 week inbred female Balb/c mice. Tachyzoites of the parasite were cultured in cell-free incubation medium (RPMI-1640), and then supernatant of the medium was loaded on an ion-exchange chromatography column. Two fractions (ESA-F(1) and ESA-F(2)) were collected from the column. For immunization of the mice, 50 were allocated into 5 groups of 10. The first, second, third, and fourth groups were immunized, twice with total-ESA, ESA-F(1), ESA-F(2) or toxoplasma lysate antigen (TLA), respectively. The fifth group was selected as a negative control group (non-immunized). The virulent RH strain of Toxoplasma gondii was used to challenge. Delayed-type hypersensitivity responses (DTHs) were measured by intra-footpad injection measuring induration at timed intervals. Lymphocyte transformation tests (LTTs) were done on lymph node cells using [3H] thymidine incorporation as an indication of reactivity. Peritoneal macrophages from sensitized mice were stimulated and nitric oxide was measured by Griess method. The ESA-F(1) and ESA-F(2) fractions were separated on poly acrylamide gel electrophoresis (PAGE) and SDS-PAGE. ESA-F(1) had 4 bands on PAGE and 14 bands on SDS-PAGE. ESA-F(2) had one band on PAGE and two bands on SDS-PGE. Sensitized mice showed DTH and lymphocyte transformation responses to total-ESA, ESA-F(1), and ESA-F(2) and peritoneal macrophages produce nitric oxide following stimulation. In challenge experiments, all non-immunized mice died within 10 days, whereas immunized mice survived for longer time periods (P<0.05). The highest survival rate was observed in mice that immunized with ESA-F(2). We suggest that these antigens especially ESA-F(2) should be of value for the development of new strategies for immunization against toxoplasmosis.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12695037     DOI: 10.1016/s0304-4017(03)00044-x

Source DB:  PubMed          Journal:  Vet Parasitol        ISSN: 0304-4017            Impact factor:   2.738


  21 in total

1.  Antibody and cytokine responses to Giardia excretory/secretory proteins in Giardia intestinalis-infected BALB/c mice.

Authors:  Juan C Jiménez; Josette Fontaine; Colette Creusy; Laurence Fleurisse; Jean-Marie Grzych; Monique Capron; Eduardo Dei-Cas
Journal:  Parasitol Res       Date:  2014-05-28       Impact factor: 2.289

2.  Evaluation of Propranolol Effect on Experimental Acute and Chronic Toxoplasmosis Using Quantitative PCR.

Authors:  Mahbobeh Montazeri; Mohammad Ali Ebrahimzadeh; Ehsan Ahmadpour; Mehdi Sharif; Shahabeddin Sarvi; Ahmad Daryani
Journal:  Antimicrob Agents Chemother       Date:  2016-11-21       Impact factor: 5.191

3.  Increased circulating levels of SDF-1 (CXCL12) in type 2 diabetic patients are correlated to disease state but are unrelated to polymorphism of the SDF-1β gene in the Iranian population.

Authors:  Reza Derakhshan; Mohammad Kazemi Arababadi; Zahra Ahmadi; Mojgan Noroozi Karimabad; Vajihe Akbarpour Salehabadi; Mehdi Abedinzadeh; Hossein Khorramdelazad; Parisa Balaei; Derek Kennedy; Gholamhossein Hassanshahi
Journal:  Inflammation       Date:  2012-06       Impact factor: 4.092

4.  Interleukin-10 Serum Levels after Vaccination with In Vivo Prepared Toxoplasma gondii Excreted/Secreted Antigens.

Authors:  Seyed Hossein Abdollahi; Fateme Ayoobi; Hossein Khorramdelazad; Gholamhossein Hassanshahi; Behzad Nasiri Ahmadabadi; Mohammadtaghi Rezayati; Ali Ravary; Ali Shamsizadeh; Mohammad Kazemi Arababadi
Journal:  Oman Med J       Date:  2013-03

Review 5.  Significance of CXCL12 in type 2 diabetes mellitus and its associated complications.

Authors:  Mojgan Noroozi Karimabad; Gholamhossein Hassanshahi
Journal:  Inflammation       Date:  2015-04       Impact factor: 4.092

6.  A comparative study between excretory/secretory and autoclaved vaccines against RH strain of Toxoplasma gondii in murine models.

Authors:  Hayam Mohamed Ezz Eldin; Hanan Hussein Kamel; Abeer Fathy Badawy; Lobna Sadek Shash
Journal:  J Parasit Dis       Date:  2013-11-20

7.  Immunization with excreted-secreted antigens reduces tissue cyst formation in pigs.

Authors:  Yanhua Wang; Delin Zhang; Guangxiang Wang; Hong Yin; Meng Wang
Journal:  Parasitol Res       Date:  2013-08-15       Impact factor: 2.289

8.  Levels of Transforming Growth Factor-Beta After Immunization of Mice With in vivo prepared Toxoplasma gondii Excretory/Secretory Proteins.

Authors:  Seyed Hossein Abdollahi; Fateme Ayoobi; Hossein Khorramdelazad; Behzad Nasiri Ahmadabadi; Mohammadtaghi Rezayati; Mohammad Kazemi Arababadi; Mohammad Zare-Bidaki
Journal:  Jundishapur J Microbiol       Date:  2015-05-31       Impact factor: 0.747

Review 9.  Research advances in microneme protein 3 of Toxoplasma gondii.

Authors:  Yanhua Wang; Hong Yin
Journal:  Parasit Vectors       Date:  2015-07-22       Impact factor: 3.876

10.  Cysticercus cellulosae antigens in the serodiagnosis of neurocysticercosis.

Authors:  Subhash Chandra Parija; Ar Gireesh
Journal:  Trop Parasitol       Date:  2011-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.